Deciphering the context-dependent roles of TGF-β across cancer stages and developing strategies to selectively target its pro-tumorigenic functions—while preserving its tumor-suppressive activity—may offer novel therapeutic opportunities for cervical cancer. Here, TGFB1 is linked to cervical carcinoma.